+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer

Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer

American Journal of Translational Research 7(7): 1246-1259

Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype for which there is a need to identify new therapeutic targets. Full-length estrogen receptor beta (ERβ1) may be a possible target given its antiproliferative effects on breast cancer cells. The prognostic significance of ERβ in breast cancer subtypes has remained elusive, and disparate results observed across previously published reports might be due to the detection of multiple ERβ isoforms, the lack of specific antibodies and the use of different cutoffs to define ERβpositivity. The objective of this retrospective study was to determine the association between ERβ1 expression and disease-free and overall survival, as well as Ki67 expression, in non-metastatic TNBC. Immunohistochemical protocols were optimized using xenograft tissues obtained from a breast cancer cell line with inducible ERβ1 expression. ERβ1 localization and expression were assessed in two cohorts of TNBC using the VECTRA(TM) platform. There was a close relationship between nuclear and cytoplasmic ERβ1 expression. ERβ1 was expressed in a subset of TNBCs, but its expression was significantly associated with Ki67 in only one of the cohorts. There was no significant association between ERβ1 expression and disease-free and overall survival in either cohort. Although these results suggest that ERβ1 expression alone may not be informative in TNBCs, this study provides a new strategy for optimizing and objectively measuring ERβ1 expression in tissues, which may provide a standard for ERβ1 immunohistochemistry in future large-scale clinical studies aimed at better understanding the role of ERβ1 in breast cancer.

(PDF emailed within 1 workday: $29.90)

Accession: 058637128

Download citation: RISBibTeXText

PMID: 26328009

Related references

Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer. Medicine 94(46): E2066, 2016

Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer. Experimental and Therapeutic Medicine 9(6): 2147-2150, 2015

Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index. Clinical Breast Cancer 17(1): 41-47, 2016

Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients. Clinical Cancer Research 10(2): 491-498, 2004

Prognostic significance of androgen receptor expression in HER2-positive and triple-negative breast cancer. Polish Journal of Pathology 69(2): 157-168, 2018

Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. Cancers 6(3): 1351-1362, 2014

The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer. Oncotarget 8(44): 76974-76986, 2017

Survival outcome of weak estrogen/progesterone receptor expression in HER2 negative breast cancer is similar to triple negative breast cancer. European Journal of Surgical Oncology 43(10): 1855-1861, 2017

Expression of ROR1 has prognostic significance in triple negative breast cancer. Virchows Archiv 468(5): 589-595, 2017

Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer. Bmc Clinical Pathology 18: 9, 2018

Expression of estrogen receptors beta in triple negative breast cancer. 2007

COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients. Medical Oncology 31(6): 989, 2015

Research progress on significance of androgen receptor and epidermal growth factor receptor expression in estrogen receptor-negative and progesterone receptor-negative breast cancer. Zhonghua Bing Li Xue Za Zhi 47(3): 226-229, 2018

The prognostic significance of cyclin D1 expression in patients with triple-negative breast cancer. Journal of B.U.On. 22(4): 947-952, 2017

Prognostic significance of LAPTM4B and p27kip1 expression in triple-negative breast cancer. Cancer Biomarkers 2019, 2019